CALR and neoplasm: As CRT and ATP operate on dendritic cell receptors to activate dendritic cells (DCs) and support the presentation of tumour antigens to cytotoxic T cells17,18 we looked for evidence of dendritic cell activation by investigating whether dendritic cells would interact with cells that had been treated with the βGBP molecule.